Biota Pharmaceuticals Inc

Type: Company
Name: Biota Pharmaceuticals Inc
First reported Jul 11 2014 - Updated Jul 11 2014 - 1 reports

5 Stocks Under $10 Set to Soar

 DELAFIELD, Wis. (Stockpickr) -- There isn't a day that goes by on Wall Street when certain stocks trading for $10 a share or less don't experience massive spikes higher. Traders savvy enough to follow the low-priced names and trade them with discipline ... [Published The Street Latest - Jul 11 2014]
First reported Jul 03 2014 - Updated Jul 04 2014 - 2 reports

Biota Pharmaceuticals EVP Acquires $28,600 in Stock (BOTA)

Biota Pharmaceuticals (NASDAQ:BOTA) EVP Joseph M. Patti bought 10,000 shares of the stock in a transaction that occurred on Monday, June 30th. The stock was purchased at an average cost of $2.86 per share, for a total transaction of $28,600.00. Following ... [Published American Banking News - Jul 04 2014]
First reported Jul 02 2014 - Updated Jul 02 2014 - 2 reports

Insider Buying: Biota Pharmaceuticals EVP Acquires 10,000 Shares of Stock (BOTA)

Biota Pharmaceuticals (NASDAQ:BOTA) EVP Joseph M. Patti acquired 10,000 shares of Biota Pharmaceuticals stock in a transaction dated Monday, June 30th. The stock was purchased at an average cost of $2.86 per share, for a total transaction of $28,600.00. ... [Published American Banking News - Jul 02 2014]
First reported Jun 30 2014 - Updated Jul 01 2014 - 2 reports

Biota Pharmaceuticals EVP Buys $14,050 in Stock (BOTA)

Biota Pharmaceuticals (NASDAQ:BOTA) EVP Joseph M. Patti acquired 5,000 shares of Biota Pharmaceuticals stock in a transaction dated Friday, June 27th. The stock was purchased at an average price of $2.81 per share, with a total value of $14,050.00. Following ... [Published American Banking News - Jul 01 2014]
First reported Jun 04 2014 - Updated Jun 04 2014 - 1 reports

Research and Markets: Biota Pharmaceuticals, Inc. - Product Pipeline Review - 2014

DUBLIN--(BUSINESS WIRE)--Research and Markets (http://www.researchandmarkets.com/research/965h3w/biota) has announced the addition of the "Biota Pharmaceuticals, Inc. - Product Pipeline Review - 2014" company profile to their offering. This report provides ... [Published Business Wire Health News - Jun 04 2014]

Quotes

Biota Pharmaceuticals president and CEO Russell Plumb said: "We are pleased to augment our ongoing Phase 2 IGLOO clinical trial of LANI with these important studies and anticipate initiating another Phase 1/2 clinical study next month in children aged 5-17 infected with influenza." The company expects top-line results from both of these clinical studies in the first half of 2014. Latest News

More Content

All (21) | News (10) | Reports (0) | Blogs (1) | Audio/Video (0) | Fact Sheets (0) | Press Releases (10)
sort by: Date | Relevance
5 Stocks Under $10 Set to Soar [Published The Street Latest - Jul 11 2014]
Biota Pharmaceuticals EVP Acquires $28,600 in S... [Published American Banking News - Jul 04 2014]
JOSEPH M. PATTI of Biota Pharmaceuticals, Inc. ... [Published Individual.com - Jul 03 2014]
Insider Buying: Biota Pharmaceuticals EVP Acqui... [Published American Banking News - Jul 02 2014]
Insider Buying: Biota Pharmaceuticals EVP Acqui... [Published American Banking News - Jul 02 2014]
Biota Pharmaceuticals EVP Buys $14,050 in Stock... [Published American Banking News - Jul 01 2014]
Insider Buying: Biota Pharmaceuticals EVP Buys ... [Published American Banking News - Jun 30 2014]
Research and Markets: Biota Pharmaceuticals, In... [Published Business Wire Health News - Jun 04 2014]
Biota Announces Restructuring Plan [Published GlobeNewswire: Advertising News - Jun 02 2014]
34% Drop in Biota Pharmaceutical, Inc.'s Stock ... [Published Financial Services - May 12 2014]
Faruqi & Faruqi, LLP Encourages Investors Who S... [Published Financial Services - May 10 2014]
Biota Provides Update on BARDA Contract for Lan... [Published GlobeNewswire: Advertising News - May 08 2014]
Biota Pharmaceuticals Reports Third Quarter 201... [Published GlobeNewswire: Advertising News - May 06 2014]
SHAREHOLDER ALERT: Pomerantz Law Firm Investiga... [Published Financial Services - Apr 29 2014]
Biota Pharmaceuticals, Inc. Announces Upcoming ... [Published GlobeNewswire: Acquisitions News - Apr 29 2014]
Biota Pharmaceuticals, Inc. to Present at the 2... [Published GlobeNewswire: Acquisitions News - Feb 24 2014]
Biota Pharmaceuticals Reports Second Quarter 20... [Published GlobeNewswire: Acquisitions News - Feb 10 2014]
Biota Pharmaceuticals to Host Conference Call t... [Published GlobeNewswire: Acquisitions News - Feb 03 2014]
Biota reports that laninamivir octanoate is app... [Published Pharmaceutical Business Review - Dec 24 2013]
8-K - Biota Pharmaceuticals, Inc. (0000072444) ... [Published SEC Filings - Nov 21 2013]
Biota initiates additional clinical trials of l... [Published Pharmaceutical Business Review - Nov 21 2013]
1
Content Volume
Document Volume
Network
Network

Blogs

sort by: Date | Relevance
Research and Markets: Biota Pharmaceuticals, In... [Published Business Wire Health News - Jun 04 2014]
DUBLIN--(BUSINESS WIRE)--Research and Markets (http://www.researchandmarkets.com/research/965h3w/biota) has announced the addition of the "Biota Pharmaceuticals, Inc. - Product Pipeline Review - 2014" company profile to their offering. This report provides ...
1

Press Releases

sort by: Date | Relevance
Biota Announces Restructuring Plan [Published GlobeNewswire: Advertising News - Jun 02 2014]
34% Drop in Biota Pharmaceutical, Inc.'s Stock ... [Published Financial Services - May 12 2014]
Faruqi & Faruqi, LLP Encourages Investors Who S... [Published Financial Services - May 10 2014]
Biota Provides Update on BARDA Contract for Lan... [Published GlobeNewswire: Advertising News - May 08 2014]
Biota Pharmaceuticals Reports Third Quarter 201... [Published GlobeNewswire: Advertising News - May 06 2014]
1 2
Contact Us
Sales
Support


Freebase CC-BY Some image thumbnails are sourced from Freebase, licensed under CC-BY

Copyright (C) 2014 Silobreaker Ltd. All rights reserved.
The selection and placement of stories and images on any Silobreaker page are determined automatically by a computer program.
The time or date displayed reflects when an article was added to or updated in Silobreaker.